65
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

High Urine Albumin-to-Creatinine Ratio is Associated with Increased Arterial Stiffness in Diabetes: A Chinese Cross-Sectional Study

ORCID Icon, , , , , , , , & show all
Pages 2121-2133 | Received 04 Jan 2024, Accepted 13 May 2024, Published online: 23 May 2024

References

  • Sukkar L, Kang A, Hockham C, et al. Incidence and associations of chronic kidney disease in community participants with diabetes: a 5-year prospective analysis of the EXTEND45 study. Diabetes Care. 2020;43(5):982–990. doi:10.2337/dc19-1803
  • O’Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol. 2007;50(1):1–13. doi:10.1016/J.JACC.2006.12.050
  • Ford ML, Tomlinson LA, Chapman TPE, Rajkumar C, Holt SG. Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension. 2010;55(5):1110–1115. doi:10.1161/HYPERTENSIONAHA.109.143024
  • Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–1327. doi:10.1016/j.jacc.2009.10.061
  • Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63(7):636–646. doi:10.1016/J.JACC.2013.09.063
  • Muhammad IF, Borné Y, Östling G, et al. Arterial stiffness and incidence of diabetes: a population-based cohort study. Diabetes Care. 2017;40(12):1739–1745. doi:10.2337/dc17-1071
  • Zheng M, Zhang X, Chen S, et al. Arterial stiffness preceding diabetes: a longitudinal study. Circ Res. 2020;127(12):1491–1498. doi:10.1161/CIRCRESAHA.120.317950
  • Wang X, Bao W, Liu J, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2013;36(1):166–175. doi:10.2337/dc12-0702
  • Del Giorno R, Troiani C, Gabutti S, Stefanelli K, Gabutti L. Comparing oscillometric and tonometric methods to assess pulse wave velocity: a population-based study. Ann Med. 2021;53(1):1–16. doi:10.1080/07853890.2020.1794538
  • Munakata M. Brachial-ankle pulse wave velocity: background, method, and clinical evidence. Pulse. 2016;3(3–4):195–204. doi:10.1159/000443740
  • Kimoto E, Shoji T, Shinohara K, et al. Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes. 2003;52(2):448–452. doi:10.2337/diabetes.52.2.448
  • Sincer I, Gunes Y, Mansiroglu AK, Cosgun M, Aktas G. Association of mean platelet volume and red blood cell distribution width with coronary collateral development in stable coronary artery disease. Adv Interv Cardiol. 2018;14(3):263–269. doi:10.5114/aic.2018.78329
  • Jain S, Khera R, Corrales-Medina VF, Townsend RR, Chirinos JA. Inflammation and arterial stiffness in humans. Atherosclerosis. 2014;237(2):381–390. doi:10.1016/j.atherosclerosis.2014.09.011
  • Bilgin S, Kurtkulagi O, Atak Tel BM, et al. Does C-reactive protein to serum Albumin Ratio correlate with diabetic nephropathy in patients with type 2 diabetes mellitus? The CARE TIME study. Prim Care Diabetes. 2021;15(6):1071–1074. doi:10.1016/j.pcd.2021.08.015
  • Aktas G. Serum C-reactive protein to albumin ratio as a reliable marker of diabetic neuropathy in type 2 diabetes mellitus. Biomol Biomed. Epub 2024 April 14.
  • Ridker PM. A test in context: high-sensitivity C-reactive protein. J Am Coll Cardiol. 2016;67(6):712–723. doi:10.1016/j.jacc.2015.11.037
  • Lyngbakken MN, Myhre PL, Røsjø H, Omland T. Novel biomarkers of cardiovascular disease: applications in clinical practice. Crit Rev Clin Lab Sci. 2019;56(1):33–60. doi:10.1080/10408363.2018.1525335
  • Upadhyay A, Larson MG, Guo CY, et al. Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant. 2011;26(3):920–926. doi:10.1093/ndt/gfq471
  • Zhou T, Huang X, Cai X, Xie L. Combined treatment of irbesartan and diltiazem ameliorates endothelium dependent vasodilatation in hypertensives. Clin Exp Hypertens. 2017;39(7):612–618. doi:10.1080/10641963.2017.1306537
  • Sun Z. Aging, arterial stiffness, and hypertension. Hypertension. 2015;65(2):252–256. doi:10.1161/HYPERTENSIONAHA.114.03617
  • Chen SC, Chang JM, Liu WC, et al. Brachial-ankle pulse wave velocity and rate of renal function decline and mortality in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(4):724–732. doi:10.2215/CJN.07700910
  • McFarlane PA. Testing for albuminuria in 2014. Can J Diabetes. 2014;38(5):372–375. doi:10.1016/j.jcjd.2014.07.221
  • Anderson RJ, Bahn GD, Emanuele NV, Marks JB, Duckworth WC. Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care. 2014;37(10):2782–2788. doi:10.2337/DC14-0284
  • Wang J, Wang F, Liu S, Zhou M, Zhang L, Zhao M. Reduced kidney function, albuminuria, and risks for all-cause and cardiovascular mortality in China: a population-based cohort study. BMC Nephrol. 2017;18(1):188. doi:10.1186/s12882-017-0603-9
  • Lees JS, Welsh CE, Celis-Morales CA, et al. Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nat Med. 2019;25(11):1753–1760. doi:10.1038/s41591-019-0627-8
  • Sung KC, Ryu S, Lee JY, et al. Urine albumin/creatinine ratio below 30 mg/g is a predictor of incident hypertension and cardiovascular mortality. J Am Heart Assoc. 2016;5(9):e003245. doi:10.1161/JAHA.116.003245
  • World Health Organization. Guidelines on second-and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus. Br J Psychiatry. 2018.
  • Guo W, Li XN, Li J, et al. Increased plasma miR-146a levels are associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus. J Diabetes Complications. 2020;34(12):107725. doi:10.1016/j.jdiacomp.2020.107725
  • Ohkuma T, Ninomiya T, Tomiyama H, et al. Brachial-ankle pulse wave velocity and the risk prediction of cardiovascular disease: an individual participant data meta-analysis. Hypertens. 2017;69(6):1045–1052. doi:10.1161/HYPERTENSIONAHA.117.09097
  • Jiang Y, Fan F, Jia J, et al. Brachial–ankle pulse wave velocity is independently associated with urine albumin-to-creatinine ratio in a Chinese community-based cohort. Int Urol Nephrol. 2020;52(4):713–720. doi:10.1007/s11255-020-02404-2
  • Xu X, He J, Wang S, et al. Ankle-brachial index and brachial-ankle pulse wave velocity are associated with albuminuria in community-based Han Chinese. Clin Exp Hypertens. 2016;38(7):618–623. doi:10.1080/10641963.2016.1182177
  • Liu CS, Pi-Sunyer FX, Li CI, et al. Albuminuria is strongly associated with arterial stiffness, especially in diabetic or hypertensive subjects--a population-based study (Taichung Community Health Study, TCHS). Atherosclerosis. 2010;211(1):315–321. doi:10.1016/J.ATHEROSCLEROSIS.2010.02.015
  • Smith A, Karalliedde J, De Angelis L, Goldsmith D, Viberti G. Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J Am Soc Nephrol. 2005;16(4):1069–1075. doi:10.1681/ASN.2004090769
  • Bae JH, Park EG, Kim S, Kim SG, Hahn S, Kim NH. Effects of sodium-glucose cotransporter 2 inhibitors on renal outcomes in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Sci Rep. 2019;9(1):13009. doi:10.1038/s41598-019-49525-y
  • Cardoso R, Graffunder FP, Ternes CMP, et al. SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: a systematic review and meta-analysis. eClinicalMedicine. 2021;36:100933. doi:10.1016/j.eclinm.2021.100933
  • Kristensen SL, Rørth R, Jhund PS, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol. 2019;7(10):776–785. doi:10.1016/S2213-8587(19)30249-9
  • Gilbert RE, Connelly KA. Reduction in the incidence of myocardial infarction with sodium-glucose linked cotransporter-2 inhibitors: evident and plausible. Cardiovasc Diabetol. 2019;18(1):6. doi:10.1186/s12933-019-0812-6
  • Karakasis P, Patoulias D, Fragakis N, Klisic A, Rizzo M. Effect of tirzepatide on albuminuria levels and renal function in patients with type 2 diabetes mellitus: a systematic review and multilevel meta-analysis. Diabetes Obes Metab. 2024;26(3):1090–1104. doi:10.1111/dom.15410
  • Agarwal R, Tu W, Farjat AE, et al. Impact of finerenone-induced albuminuria reduction on chronic kidney disease outcomes in type 2 diabetes. Ann Intern Med. 2023;176(12):1606–1616. doi:10.7326/M23-1023
  • Nikolaidou B, Gkaliagkousi E, Anyfanti P, et al. The impact of hyperglycemia on urinary albumin excretion in recent onset diabetes mellitus type II. BMC Nephrol. 2020;21(1):119. doi:10.1186/S12882-020-01774-0
  • Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia. 2008;51(5):714–725. doi:10.1007/S00125-008-0961-8
  • Yan X, Sano M. God gives IL-19 with both hands: anti-inflammatory but pro-angiogenic. J Mol Cell Cardiol. 2015;80:20–22. doi:10.1016/J.YJMCC.2014.12.012
  • Heerspink HJL, Gansevoort RT. Albuminuria is an appropriate therapeutic target in patients with CKD: the pro view. Clin J Am Soc Nephrol. 2015;10(6):1079–1088. doi:10.2215/CJN.11511114